Title
Category
Credits
Event date
Cost
Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study
  • Psychotic Disorders
  • Substance Use Disorders
  • COVID-19
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Identifying risk factors that predispose individuals to negative COVID-19 outcomes is important. The current study examined the association between substance use disorders, psychiatric diagnosis, and COVID-19–related clinical outcomes.
The Co-occurrence of Gastrointestinal Symptoms and Psychosis: Diagnostic Considerations
  • Psychotic Disorders
  • Gastroenterology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
There are numerous clinical scenarios in which gastrointestinal and psychotic symptoms commonly co-occur; thus, it is important that both psychiatrists and primary care physicians have a familiarity with the differential diagnosis.
Part 3: Impact of Side Effects on Adherence to Schizophrenia Treatment
  • Adherence
  • Antipsychotics
  • Cognition
  • Neuropsychiatric Disorders
  • Patient/Physician Communication
  • Psychopharmacology
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Sexual Dysfunction
  • Side Effects
  • Veterans and Military Issues
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Side effects from medication have the greatest impact on adherence for patients with Schizophrenia. They lower quality of life, daily functioning, and satisfaction.
Part 2: Chasing Cognitive and Negative Symptoms: Unmet Treatment Needs of Patients with Schizophrenia
  • Adherence
  • Antipsychotics
  • Cognition
  • Neuropsychiatric Disorders
  • Patient/Physician Communication
  • Psychopharmacology
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Sexual Dysfunction
  • Side Effects
  • Veterans and Military Issues
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Negative symptoms contribute to poor functional outcomes in schizophrenia. Evaluating different symptom domains and understanding the disorder’s reward circuitry can help with intervention and patients’ leading more fulfilling lives.
Measurement-Based Care for Psychotic Disorders in the Veterans Health Administration: Current Practices and Future Directions
  • Psychotic Disorders
  • Veterans and Military Issues
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Measurement-based care (MBC) can improve patient outcomes, but data on its use in psychosis are sparse. This study examined the use of patient-reported outcome measures in veterans with psychosis to identify candidate measures for psychosis-related MBC.
Postpartum Depression and Psychosis and Subsequent Severe Mental Illnesses in Mothers and Neurodevelopmental Disorders in Children: A Nationwide Study
  • Bipolar Disorder
  • Depression
  • Attention-Deficit/Hyperactivity Disorder
  • Autism Spectrum Disorders
  • Child and Adolescent Psychiatry
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Women’s Mental Health
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Is there an association between postpartum depression or psychosis and subsequent disorders in either the mother or the child who is exposed to postpartum maternal illness?
Tardive Dyskinesia: Subtle Symptoms and the Huge Impact of Early Recognition and Intervention
  • Movement Disorders
  • Psychotic Disorders
  • Side Effects
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Clinicians should screen regularly for signs and symptoms of tardive dyskinesia and educate patients and caregivers on what to look for and report, leading to earlier intervention and better quality of life.
Addressing Patients’ Unmet Needs to Improve Outcomes in Schizophrenia
  • Adherence
  • Antipsychotics
  • Delivery of Care
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Side Effects
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What are some of the challenges you face in overcoming adherence issues and providing patient-centered care for people living with schizophrenia? Drs Harvey and Kane offer evidence and clinical experience on these topics in this journal CME activity.
Relieving Caregiver Burden Through Evidence-Based Treatment for Dementia-Related Psychosis
  • Dementia
  • Geriatric Psychiatry
  • Psychotic Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Dementia-related psychosis (DRP) occurs in all forms of dementia and at all stages. What tactics should be used when talking with patients and their care partners about DRP? How is it best treated?
Part 1: A Review of Schizophrenia
  • Adherence
  • Antipsychotics
  • Cognition
  • Neuropsychiatric Disorders
  • Patient/Physician Communication
  • Psychopharmacology
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Sexual Dysfunction
  • Side Effects
  • Veterans and Military Issues
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Schizophrenia affects 1% of the world’s population largely during a patient’s most productive years. Multiple treatments are available, however many gaps to recovery exist. Learn from experts diagnostic criteria for and defining recovery in schizophrenia.

Pages